Key Takeaways
- SAS Group has acquired Ceres Biotics, a Madrid-based company specializing in microbial biofertilizers and biostimulants.
- The acquisition strengthens SAS Group’s position in microbial biosolutions and supports its long-term expansion strategy.
- Ceres Biotics brings complementary products, established European market presence, and advanced R&D capabilities.
- The transaction follows a series of acquisitions since Stirling Square Capital Partners’ entry five years ago.
- Sustainability and innovation remain central to the company's growth strategy.
SAS Group Expands Biosolutions Strategy with Ceres Biotics Acquisition
SAS Group has announced the acquisition of Ceres Biotics, a Spain-based company focused on innovation in microbial biofertilizer and biostimulant solutions. Headquartered in Madrid, Ceres Biotics specializes in the development of microbial products designed to support agricultural productivity and soil health.
The acquisition represents a further step in the group’s expansion roadmap, which began five years ago following the entry of Stirling Square Capital Partners. Since then, SAS Group has completed multiple acquisitions, including Biovert in 2023, Pevesa Agroscience in 2024, and Aqua do Brasil and CODIAGRO last year.
Strengthening SAS Group's Capabilities in Microbial Biosolutions
With the addition of Ceres Biotics, SAS Group expands its presence in the growing microbial biosolutions segment. According to the company, Ceres Biotics brings a complementary product portfolio and strong expertise in microorganisms, alongside established customer relationships across Europe.
“This is an incredibly exciting moment for SAS Group as we undertake an acquisition that marks our expansion into the large and growing field of microbial biosolutions,” said Eduard Vallverdú, CEO of SAS Group. He highlighted the technical expertise and growth potential of the Ceres Biotics team, noting its “best-in-class R&D capabilities” and alignment with the company's strategic direction.
R&D and Product Portfolio Alignment
Ceres Biotics is recognized for its research and development activities focused on identifying and developing efficient probiotic strains for agricultural use. The company stated that these capabilities complement its existing biosolutions portfolio and enhance its ability to deliver innovative products to global markets.
The acquisition is expected to strengthen the group's innovation pipeline by integrating microbial technologies with its broader range of agricultural biosolutions.
Supporting Long-Term Growth and Sustainability Goals
SAS Group described the acquisition as a milestone in its strategy to build a global leader in agricultural biosolutions. The company emphasized that sustainability remains a core pillar of its philosophy, with microbial solutions playing an increasingly important role in supporting more resilient and efficient farming systems.
Ceres Biotics’ presence in Europe and its focus on microbial innovation are expected to support the company's long-term growth objectives while reinforcing its commitment to sustainable agriculture.
SAS Group stated that it will continue advancing its expansion strategy through targeted investments and acquisitions aligned with its biosolutions focus.
